FDA Approved: DIMETHYL FUMARATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approves Cipla USA Inc.'s supplemental ANDA for a generic version of dimethyl fumarate. The product is indicated for relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

SUPPL AP for DIMETHYL FUMARATE (DIMETHYL FUMARATE)